Investor Presentaiton

In-house Research & Development capabilities Consistent technology absorption to develop new potential marketable products o Developed five different chemistry platforms on commercial scale o Addition of 34 New Products to the SI Platform in the last 8 years o 2 of the new piloted molecules in SI ready for commercialization R&D - Key growth driver of business o Two DSIR recognised R&D facilities working on ketene, diketene & other complex chemistries o Dedicated team of 49 employees - focused on innovations in chemistry & engineering o Unlocked value in various complex chemistries, resulting in higher margins & revenues ● Patent in European countries and USA www.laxmi.com 8

View entire presentation